Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zyxelle Supplement for Adverse Effects of Oral Contraceptives
NCT07071389Withdrawn
- Sponsor
- Lo.Li. Pharma
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Lo.Li. Pharma. Primary endpoints: Cellulite status at 3 months and Extracellular body water content at 3 months. Planned start Jan 2018; status: withdrawn.
Beyond the preview
Go deeper on NCT07071389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07071389.